About Atropos Health
Atropos Health is a private company based in New York, New York, incorporated in 2019 in Delaware. It has reported $44,325,303 raised in three offerings on Form D since August 2022. Its chief executive is Brigham Hyde.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 20, 2024 | May 31, 2024 | $32,999,989of $33.0M target | 7 | $4.7M | EquityRule 506(b) | Form D ↗ |
| Jul 28, 2023 | Aug 11, 2023 | $3,325,314of $5.0M target | 8 | $415K | EquityRule 506(b) | Form D ↗ |
| Aug 4, 2022 | Aug 18, 2022 | $8,000,000fully sold | 16 | $500K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $44,325,303 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Atropos Health's Form D filed May 31, 2024.
NS
Neil Sanghavi
Executive officer
NS
Nigam Shah
Director
MB
MS
Mike Spadafore
Director
BH
Brigham Hyde
CEO and director
SG
Saurabh Gombar
Executive officer
Earlier filings also listed James Breyer (director, last listed Aug 2023).